Tjallie van der Kooi1, Hugo Sax2,3, Didier Pittet3, Jaap van Dissel1, Birgit van Benthem1, Bernhard Walder4, Vanessa Cartier4, Lauren Clack2, Sabine de Greeff1, Martin Wolkewitz5, Stefanie Hieke5, Hendriek Boshuizen1, Jan van de Kassteele1, Annemie Van den Abeele6, Teck Wee Boo7, Magda Diab-Elschahawi8, Uga Dumpis9, Camelia Ghita10, Susan FitzGerald11, Tatjana Lejko12, Kris Leleu6, Mercedes Palomar Martinez13, Olga Paniara14, Márta Patyi15, Paweł Schab16, Annibale Raglio17, Emese Szilágyi18, Mirosław Ziętkiewicz19, Albert W Wu20, Hajo Grundmann4,21, Walter Zingg22,23. 1. RIVM National Institute for Public Health and the Environment, 3720 BA, Bilthoven, The Netherlands. 2. Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, 8091, Zurich, Switzerland. 3. Infection Control and World Health Organization Collaborating Center on Patient Safety, The University of Geneva Hospitals and Faculty of Medicine, Rue Gabrielle Perret-Gentil 4, 1211, Geneva, Switzerland. 4. Division of Anaesthesiology, University of Geneva Hospitals, Rue Gabrielle Perret-Gentil 4, 1211, Geneva, Switzerland. 5. Institute of Medical Biometry and Statistics, Faculty of Medicine, University of Freiburg, 79085, Freiburg, Germany. 6. AZ Sint-Lucas Hospital, 9000, Ghent, Belgium. 7. University Hospital Galway, Galway, H91 YR71, Ireland. 8. Medical University of Vienna, 1090, Vienna, Austria. 9. Pauls Stradins Clinical University Hospital, University of Latvia, Riga, 1002, Latvia. 10. Department of Infection Control, Institute for Emergency Cardiovascular Diseases "Prof. C.C. Iliescu", 022328, Bucharest, Romania. 11. St. Vincent's University Hospital, Dublin, D04 T6F4, Ireland. 12. University Medical Center Ljubljana, 1000, Ljubljana, Slovenia. 13. Arnau de Vilanova University Hospital, 25198, Lleida and Vall d'Hebron University Hospital and Universitat Autónoma, 08035, Barcelona, Spain. 14. Evanggelismos Hospital, 106 76, Athens, Greece. 15. Bács-Kiskun County Teaching Hospital, Kecskemét, 6000, Hungary. 16. Hospital of Silesia, 43-400, Cieszyn, Poland. 17. Papa Giovanni XXIII Hospital, 24127, Bergamo, Italy. 18. Office of the Chief Medical Officer and Szent János Hospital, Budapest, 1125, Hungary. 19. John Paul II Hospital and Dept of Anesthesiology and Intensive Care, Jagielonian University, Medical College, 30-001, Kraków, Poland. 20. John Hopkins University Bloomberg School of Public Health, Baltimore, MD, 21205, USA. 21. Institute for Infection Prevention and Hospital Epidemiology, Medical Center, University of Freiburg, 79085, Freiburg, Germany. 22. Infection Control and World Health Organization Collaborating Center on Patient Safety, The University of Geneva Hospitals and Faculty of Medicine, Rue Gabrielle Perret-Gentil 4, 1211, Geneva, Switzerland. walter.zingg@hcuge.ch. 23. Imperial College London, London, SW7 2AZ, UK. walter.zingg@hcuge.ch.
Abstract
PURPOSE: To test the effectiveness of a central venous catheter (CVC) insertion strategy and a hand hygiene (HH) improvement strategy to prevent central venous catheter-related bloodstream infections (CRBSI) in European intensive care units (ICUs), measuring both process and outcome indicators. METHODS:Adult ICUs from 14 hospitals in 11 European countries participated in this stepped-wedge cluster randomised controlled multicentre intervention study. After a 6 month baseline, three hospitals were randomised to one of three interventions every quarter: (1) CVC insertion strategy (CVCi); (2) HH promotion strategy (HHi); and (3) both interventions combined (COMBi). Primary outcome was prospective CRBSI incidence density. Secondary outcomes were a CVC insertion score and HH compliance. RESULTS:Overall 25,348 patients with 35,831 CVCs were included. CRBSI incidence density decreased from 2.4/1000 CVC-days at baseline to 0.9/1000 (p < 0.0001). When adjusted for patient and CVC characteristics all three interventions significantly reduced CRBSI incidence density. When additionally adjusted for the baseline decreasing trend, the HHi and COMBi arms were still effective. CVC insertion scores and HH compliance increased significantly with all three interventions. CONCLUSIONS: This study demonstrates that multimodal prevention strategies aiming at improving CVC insertion practice and HH reduce CRBSI in diverse European ICUs. Compliance explained CRBSI reduction and future quality improvement studies should encourage measuring process indicators.
RCT Entities:
PURPOSE: To test the effectiveness of a central venous catheter (CVC) insertion strategy and a hand hygiene (HH) improvement strategy to prevent central venous catheter-related bloodstream infections (CRBSI) in European intensive care units (ICUs), measuring both process and outcome indicators. METHODS: Adult ICUs from 14 hospitals in 11 European countries participated in this stepped-wedge cluster randomised controlled multicentre intervention study. After a 6 month baseline, three hospitals were randomised to one of three interventions every quarter: (1) CVC insertion strategy (CVCi); (2) HH promotion strategy (HHi); and (3) both interventions combined (COMBi). Primary outcome was prospective CRBSI incidence density. Secondary outcomes were a CVC insertion score and HH compliance. RESULTS: Overall 25,348 patients with 35,831 CVCs were included. CRBSI incidence density decreased from 2.4/1000 CVC-days at baseline to 0.9/1000 (p < 0.0001). When adjusted for patient and CVC characteristics all three interventions significantly reduced CRBSI incidence density. When additionally adjusted for the baseline decreasing trend, the HHi and COMBi arms were still effective. CVC insertion scores and HH compliance increased significantly with all three interventions. CONCLUSIONS: This study demonstrates that multimodal prevention strategies aiming at improving CVC insertion practice and HH reduce CRBSI in diverse European ICUs. Compliance explained CRBSI reduction and future quality improvement studies should encourage measuring process indicators.
Authors: Judith Manniën; Susan van den Hof; Jan Muilwijk; Peterhans J van den Broek; Birgit van Benthem; Jan C Wille Journal: Infect Control Hosp Epidemiol Date: 2008-12 Impact factor: 3.254
Authors: Marin L Schweizer; Heather Schacht Reisinger; Michael Ohl; Michelle B Formanek; Amy Blevins; Melissa A Ward; Eli N Perencevich Journal: Clin Infect Dis Date: 2013-10-08 Impact factor: 9.079
Authors: Lauren Clack; Walter Zingg; Sanjay Saint; Alejandra Casillas; Sylvie Touveneau; Fabricio da Liberdade Jantarada; Ursina Willi; Tjallie van der Kooi; Laura J Damschroder; Jane H Forman; Molly Harrod; Sarah Krein; Didier Pittet; Hugo Sax Journal: BMJ Qual Saf Date: 2018-06-27 Impact factor: 7.035
Authors: Nicola Vousden; Elodie Lawley; Hannah L Nathan; Paul T Seed; Muchabayiwa Francis Gidiri; Shivaprasad Goudar; Jane Sandall; Lucy C Chappell; Andrew H Shennan Journal: Lancet Glob Health Date: 2019-03 Impact factor: 26.763
Authors: Septimiu Voidazan; Sorin Albu; Réka Toth; Bianca Grigorescu; Anca Rachita; Iuliu Moldovan Journal: Int J Environ Res Public Health Date: 2020-01-25 Impact factor: 3.390